Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A glass vial with clear liquid on a lab bench in a biotechnology lab

Jun 4, 2026

Alnylam, Inceptive ink AI deal potentially worth $2B

Alnylam Pharmaceuticals has announced a significant collaboration with Inceptive Nucleics, aiming to leverage artificial intelligence (AI) for the accelerated discovery of RNA-based therapies. The initial phase of the partnership includes a $30 million investment, with potential total deal value reaching $2 billion contingent on meeting various milestones.This partnership is a key component of Alnylam's broader "Alnylam 2030" strategy, which focuses on expanding its pipeline of innovative therap
Minimalist illustration of a drug compound

Jun 4, 2026

Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive

Alnylam Pharmaceuticals has initiated a significant collaboration with Inceptive, aiming to leverage generative AI to enhance its RNA interference (RNAi) drug discovery efforts. This partnership is strategically aligned with Alnylam's objectives for its Alnylam 2030 pipeline expansion, focusing on accelerating the development of innovative RNAi therapeutics. Inceptive's AI platform is designed to identify complex biological patterns and apply them across various therapeutic contexts without the
A minimalist representation of a molecular structure in a dark color scheme.

Jun 4, 2026

Pfizer to Leverage Chai Discovery’s AI Platform

Pfizer has announced a strategic partnership with Chai Discovery to integrate advanced AI capabilities into its drug development processes.This collaboration will allow Pfizer to utilize Chai's AI platform, specifically the Chai-3 model and a customized version that incorporates Pfizer's proprietary data. The aim is to enhance Pfizer's drug discovery engine, streamlining the identification and development of new therapeutic molecules.Chai Discovery specializes in generative AI technology that ca
A DNA sample on a lab bench with a microscope in the background.

Jun 4, 2026

AI Industry Leaders Urge Congress to Regulate Genomic Data Amid New Biotech Partnerships

Leaders in the AI sector are advocating for new regulations on genomic data as the convergence of biotechnology and artificial intelligence intensifies.Prominent figures from leading AI companies are pressing Congress to establish federal regulations to protect DNA data, highlighting the growing intersection of biotechnology and machine learning. This push for regulatory measures comes on the heels of notable partnerships and developments in the industry, including a collaboration between Incept
A transcatheter mitral valve replacement system on a surgical tray in a dimly lit room.

Jun 4, 2026

Rhythm AI appoints medtech veteran Mike Dineen as new CEO

Rhythm AI has appointed Mike Dineen as its new CEO, marking a significant leadership transition for the company as it advances its Star Apollo mapping software.Dineen brings over 30 years of experience in the medtech sector, particularly in cardiovascular technologies. He has a history of guiding innovations from initial development through to market launch and acquisition. Before joining Rhythm AI, he co-founded and led Tioga Cardiovascular, where he worked on a transcatheter mitral valve repla
A tumor sample on a microscope slide in a dimly lit lab

Jun 4, 2026

SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center

SOPHiA GENETICS has announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to establish a precision medicine hub aimed at advancing precision oncology.The Memorandum of Understanding (MOU) between SOPHiA GENETICS and MSK seeks to leverage the strengths of both organizations. SOPHiA’s DDM™ platform has analyzed over 2.5 million cases since its inception, while MSK has sequenced more than 150,000 tumor samples, creating a rich dataset that integrates clinical outcome
A minimalist illustration of a syringe and a molecule on a dark background.

Jun 4, 2026

AI Investment Momentum Builds as Enterprises Prioritize High-Impact Use Cases in Q1 2026

In early 2026, enterprise adoption of artificial intelligence is accelerating, driven by a focus on ROI and strategic planning, as highlighted in BCC Research's latest report on AI investment trends.The report indicates that sectors such as technology and consumer electronics are leading in AI spending, reflecting their need for competitive positioning and infrastructure development. Notably, the life sciences and healthcare sectors are also witnessing robust investment, bolstered by strong rese
A clinical data sheet on a desk in a softly lit office

Jun 4, 2026

Century Health Raises $5M Seed Round as AI-Powered Platform Achieves 97% Accuracy in Clinical Data Abstraction

Century Health has successfully raised $5 million in a seed funding round, led by Origin Ventures, to enhance its AI-driven platform, CHARM, which boasts a remarkable 97% accuracy in clinical data abstraction.This funding round included contributions from InnovateHealth Ventures, 25madison, Next Play Ventures, and existing investors like 2048 Ventures and Alumni Ventures. The capital will be allocated towards scaling collaborations with pharmaceutical partners, expanding their provider network,
A drug compound on a laboratory notebook in a research lab

Jun 4, 2026

Meet Dalton, a new AI-powered drug discovery platform

DaltonTx has launched its AI-driven drug discovery platform, Dalton, aimed at streamlining the entire drug development process.The UK-based start-up DaltonTx has officially introduced its platform, Dalton, which is designed to optimize drug discovery from data analysis to molecular design and decision-making. This innovative platform aims to create a "continuous learning engine" that supports both small-molecule and biologic medicines. With a team comprising former scientists from AstraZeneca, E
Minimalist illustration of a voice AI agent and an insurance document

Jun 4, 2026

Athenahealth Unveils 80+ AI-Powered Revenue Cycle Management Features on athenaOne Platform

Athenahealth has introduced over 80 new AI-driven features for revenue cycle management on its athenaOne platform, targeting the automation of essential workflows in ambulatory care.The company aims to alleviate administrative burdens and enhance payment outcomes for healthcare providers by leveraging artificial intelligence. Key features include automated insurance selection, AI tools for copay accuracy, voice AI agents, express coding, expanded payer surveillance, and automated denial resoluti
A stack of research papers in a dimly lit lab, symbolizing human genetics data.

Jun 4, 2026

Genomics Launches Mystra AI Platform to Accelerate Drug Target Discovery Using Human Genetics Data

Genomics has introduced the Mystra AI platform, aiming to enhance drug target discovery by leveraging extensive human genetics data.The London-based techbio company has developed Mystra AI, a conversational AI tool designed to facilitate drug target identification and validation. This platform is already in use by prominent pharmaceutical companies and biotech startups, addressing the high failure rates in drug development, where approximately 95% of candidates fail in clinical trials. Genomics
A clipboard with a data sheet in a dark monochromatic style

Jun 4, 2026

Adlib Appoints Kristen Sauter as President & GM of Life Sciences to Accelerate Its Vertical AI Strategy

Adlib Software has appointed Kristen Sauter as President and General Manager of Life Sciences, aiming to enhance its vertical AI strategy amid increasing challenges in the industry.Sauter, who brings over two decades of experience in regulatory data and AI solutions within the pharma and biopharma sectors, previously held significant roles at Deloitte and Takeda. Her appointment signals Adlib's commitment to addressing the complexities of AI implementation in life sciences, particularly in clini